IceCure Medical Ltd (ICCM)
IceCure Medical Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Caesarea, HA, IL. The stock last traded at $3.27, down 6.84% on the session, giving a market capitalisation of $7.4M. On trailing twelve-month figures it carries a trailing P/E of -0.47, a net margin of -441.6%. Its beta of 0.47 implies it has historically moved less than the broad market.
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
IceCure Medical Ltd is most often compared with the following Healthcare names: